Abbott Laboratories (ABL BE) stock market data APIs
€106.4815
0.86(0.8%)
as of December 23, 2025
Try our APIs with
free plan!
Abbott Laboratories Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ABL.BE.
Prev. Close
106.4815
Open
107.3424
High
108.5339
Low
106.4131
52 wk Range
103.2433-132.5578
Market Cap
210 391 M
Dividends (Yield)
0.0128
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Abbott Laboratories data using free add-ons & libraries
Get Abbott Laboratories Fundamental Data
Abbott Laboratories Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Abbott Laboratories News
New
Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns?
If you have been wondering whether Abbott Laboratories is still a buy at around $125 a share, you are not alone. This is exactly the kind of stock where valuation really matters. Despite slipping abou...
Should You Hold On To BSX Stock Despite Its Premium Valuation?
Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a forward five-year price/earnings (P/E) of 27.77X, above its median as well a...
Abbott Wins FDA Clearance for Volt
This article first appeared on GuruFocus. Abbott Laboratories (NYSE:ABT) picked up a meaningful win Monday after the FDA approved its Volt Pulsed Field Ablation system for treating atrial fibrillatio...
Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib) Pulsed field ablation – o...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
